BIOGEN INC. financial data

Symbol
BIIB on Nasdaq
Location
Cambridge, MA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 06 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 222% % 36%
Quick Ratio 59% % 2.5%
Return On Equity 7.3% % -28%
Return On Assets 4.5% % -24%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 146,758,528 shares 0.26%
Common Stock, Shares, Outstanding 146,800,000 shares 0.69%
Entity Public Float $18,378,285,308 USD -45%
Common Stock, Value, Issued $100,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 146,500,000 shares 0.62%
Weighted Average Number of Shares Outstanding, Diluted 147,100,000 shares 0.82%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $9,890,600,000 USD 2.2%
Costs and Expenses $8,334,100,000 USD 7.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $1,556,500,000 USD -18%
Income Tax Expense (Benefit) $263,600,000 USD -3.7%
Net Income (Loss) Attributable to Parent $1,292,900,000 USD -21%
Earnings Per Share, Basic 8.83 USD/shares -21%
Earnings Per Share, Diluted 8.79 USD/shares -21%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current $1,342,400,000 USD -4.4%
Inventory, Net $2,168,100,000 USD -12%
Other Assets, Current $1,123,300,000 USD 49%
Assets, Current $8,974,100,000 USD 20%
Deferred Income Tax Assets, Net $292,500,000 USD -9.8%
Property, Plant and Equipment, Net $3,055,400,000 USD -4%
Operating Lease, Right-of-Use Asset $265,400,000 USD -26%
Intangible Assets, Net (Excluding Goodwill) $9,178,500,000 USD -5.3%
Goodwill $6,491,100,000 USD 0.19%
Other Assets, Noncurrent $750,600,000 USD 34%
Assets $29,439,500,000 USD 5%
Accounts Payable, Current $432,000,000 USD 1.8%
Employee-related Liabilities, Current $310,700,000 USD 7.6%
Liabilities, Current $3,349,400,000 USD -39%
Accrued Income Taxes, Noncurrent $166,400,000 USD 6.2%
Deferred Income Tax Liabilities, Net $507,600,000 USD 166%
Operating Lease, Liability, Noncurrent $290,400,000 USD -13%
Other Liabilities, Noncurrent $748,500,000 USD 2.2%
Liabilities $11,182,700,000 USD -1.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax $182,000,000 USD -34%
Retained Earnings (Accumulated Deficit) $20,552,700,000 USD 6.7%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $18,256,800,000 USD 9.2%
Liabilities and Equity $29,439,500,000 USD 5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $259,300,000 USD -53%
Net Cash Provided by (Used in) Financing Activities $23,000,000 USD 95%
Net Cash Provided by (Used in) Investing Activities $47,300,000 USD 28%
Common Stock, Shares Authorized 1,000,000,000 shares 0%
Common Stock, Shares, Issued 170,500,000 shares 0.59%
Common Stock, Par or Stated Value Per Share 0.0005 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3,008,500,000 USD 27%
Deferred Tax Assets, Valuation Allowance $832,200,000 USD -18%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Operating Lease, Liability $370,800,000 USD -12%
Depreciation $272,800,000 USD -4.8%
Payments to Acquire Property, Plant, and Equipment $37,100,000 USD -19%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $1,247,100,000 USD -24%
Lessee, Operating Lease, Liability, to be Paid $445,500,000 USD -12%
Property, Plant and Equipment, Gross $5,986,600,000 USD 2.3%
Operating Lease, Liability, Current $80,400,000 USD -6.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two $97,500,000 USD 10%
Lessee, Operating Lease, Liability, to be Paid, Year One $94,100,000 USD -9%
Operating Lease, Weighted Average Discount Rate, Percent 0.046 pure 2.2%
Deferred Income Tax Expense (Benefit) $27,800,000 USD -170%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $74,700,000 USD -11%
Lessee, Operating Lease, Liability, to be Paid, Year Three $56,400,000 USD -36%
Deferred Tax Assets, Operating Loss Carryforwards $1,082,800,000 USD -20%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 8,000,000 shares 0%
Unrecognized Tax Benefits $180,000,000 USD -3.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four $26,100,000 USD -48%
Additional Paid in Capital $863,100,000 USD 52%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $135,700,000 USD 23%
Depreciation, Depletion and Amortization $183,200,000 USD 24%
Deferred Tax Assets, Net of Valuation Allowance $2,305,100,000 USD -21%
Share-based Payment Arrangement, Expense $301,500,000 USD -9.9%
Interest Expense $267,500,000 USD 6.9%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%